-
-
(EMAILWIRE.COM, February 07, 2025 ) The global Cochlear Implants Market is anticipated to grow from USD 2.80 billion in 2024 to USD 4.73 billion in 2030 at a compound annual growth rate of 9.2%. The cochlear implants market is driven by factors such as the rising prevalence of hearing loss, particularly among the geriatric population, and the growing awareness of hearing rehabilitation options. Additionally, AI-enabled audio processing, pediatrics implantations for speech development, and advancement of surgical techniques create opportunities for better accessibility and improvement in the prognosis. The markets of emerging economies have a host of opportunities regarding developing low-cost implants and also integrating telemedicine for managing the post-implant case.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94935516
The rising prevalence of hearing loss problems, increasing prevalence of minimally invasive surgery, and growing older population contribute to the market growth. Government initiatives, insurance coverage, and reimbursement policies in many regions have improved the accessibility and affordability of cochlear implants, thus increasing its adoption. Besides, technological innovations in cochlear implants and integration with digital health platforms would create growth opportunities for players operating in this market.
In 2023, the cochlear implant systems segment held the largest share of the cochlear implants market, by component type segment.
Based on component type, the global cochlear implants market is segmented into cochlear implant systems and upgrades & accessories. In 2023, cochlear implant systems led the cochlear implants market. The large market share of this segment is driven by the advancements in technology, increasing demand for improved hearing solutions, coupled with the global expansion of healthcare services. However, the rising prevalence of hearing loss, particularly among children and older adults, is a major driver for this segment.
The adults segment is projected to witness the highest growth rate in the cochlear implants market, in 2023, by patient type
The market for cochlear implants is divided into segments based on patient type, such as adults and pediatrics. Hearing loss is prevalent among older adults, making this age group a significant contributor to the growth of the adults segment. Additionally, due to improved awareness of advanced hearing solutions and their ability to significantly enhance quality of life, combined with better surgical outcomes, this segment of the cochlear implants market is projected to develop at the fastest rate.
The North America market the highest share of cochlear implants market in 2023.
The global cochlear implants market is segmented into six distinct regions: North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and GCC Countries. The North America holds the highest share of 38.1% of global cochlear implants market in 2023. The large share of North America can be attributed to the region’s highly developed healthcare infrastructure and reimbursement system, the increasing number of ENT specialists, and patient awareness about the newly introduced treatment procedures and technologies in the market. The rising prevalence of hearing loss, increasing geriatric population, and rising patient preference for cochlear implants further drive the North American market growth.
Prominent players in the cochlear implants market include Cochlear Ltd. (Australia), Sonova (Switzerland), MED-EL Medical Electronics (Austria), Zhejiang Nurotron Biotechnology Co., Ltd. (China), Neubio AG (Switzerland), TODOC Co., Ltd. (South Korea), and Shanghai Listent Medical Tech Co., Ltd. (China).
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94935516
Recent Developments of Cochlear implants Market
-In September 2024, MED-EL Medical Electronics, Austria, launched the audio processor SONNET 3. This is an advanced BTE audio processor that boasts exceptional hearing performance and seamless connectivity for cochlear implant users. With state-of-the-art technology, the SONNET 3 will set another milestone in further improving the hearing experience and seamlessly integrating into daily life.
-In May 2024, Cochlear Ltd. acquired Demant’s Oticon Medical Cochlear Implant business. The acquisition strengthened Cochlears market position by expanding its customer base and technology portfolio.
